Faculty

Institution

Unit

Venue

Erik S. Mittra, M.D., Ph.D.

Professor of Diagnostic Radiology

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Diagnostic Radiology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Division Of Molecular Imaging And Therapy

Department Of Diagnostic Radiology

Division Of Nuclear Medicine And Molecular Imaging

Nuclear Medicine and Molecular Imaging

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Erik S. Mittra, M.D., Ph.D., is a Professor of Diagnostic Radiology at Oregon Health & Science University. His research focuses on cancer imaging, nuclear medicine, and theranostics, with specific interests in positron emission tomography (PET), radiopharmaceutical dosimetry, and targeted radionuclide therapy for neuroendocrine tumors. His recent work includes dosimetry analyses from the Phase III NETTER-1 trial of [177Lu]Lu-DOTATATE, safety and dosimetry results for [177Lu]Lu-NeoB targeting gastrin-releasing peptide receptors, and clinical guidelines for symptom management and radiation safety following radiopharmaceutical therapies. He has also published on theranostic protocol development and national practice surveys, contributing to the standardization of molecular imaging and therapy in oncology.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Erik S. Mittra, M.D., Ph.D.

Oregon Health & Science University

Professor of Diagnostic Radiology

You can click a keyword to filter the displayed items

radiology oncology medical imaging radiation oncology nuclear medicine medicine cancer imaging positron emission tomography computed tomography biomedical imaging ct scan cancer research health sciences nuclear magnetic resonance pet-mri brain tumor research molecular imaging cancer treatment endocrine oncology respiratory medicine radiation cancer care radiation therapy prostate cancer neuroendocrine disorders oncologic imaging gliomas pharmacotherapy cancer biology neuroradiology bone research radiopharmaceutical therapy medicinal research experimental medicine magnetic resonance imaging theranostics brain imaging jama oncology radiation biology dosimetry lymphoid neoplasia malignant disease ventilation neuroendocrine tumors diagnostic imaging clinical evidence mechanical science thyroid leukemia orthopedic biomechanics liver cancer cancer management endocrine-related cancers imaging agent gastrointestinal oncology bone density clinical guidance skeletal metastases prospective evaluation livestock science musculoskeletal science biliary cancer clinical mycology sheep trabecular bone microstructural properties spect ventilation images asco guideline current practice intracranial malignancies midgut neuroendocrine tumours gastroenteropancreatic neuroendocrine tumors exploratory study mdp scintigraphy exploratory clinical trial midgut neuroendocrine tumors dosimetric studies diagnosis cancer letter medical image computing anatomical pathology bone fracture functional imaging surgical pathology therapeutic targets musculoskeletal disorders oral radiology medical optical imaging orthopaedic research clinical investigation confocal microscopy sarcoma histopathology surgery biological imaging biomedical engineering osteoporosis clinical research translational medicine medical physics neuro-oncology neuroimaging oral pathology surgical oncology nuclear cardiology orthopaedic surgery thoracic oncology mesothelioma nature method translational research pathology

Notable Scholarly Works

Notable Federal Grants

Collaborators

Dosimetry-Guided [ 131 I]Mibg Therapy in a Hemodialysis-Dependent Paraganglioma Patient. Journal of Nuclear Medicine (2025)

mibg therapyurologycancer treatmentdialysis therapyoncologyneuro-oncologybrain tumor researchradiation oncologysurgical oncologypharmacotherapyblood purificationgliomas

Dosimetry of [ 177 Lu]Lu-Dotatate in Patients With Advanced Midgut Neuroendocrine Tumors: Results From a Substudy of the Phase III Netter-1 Trial. Journal of Nuclear Medicine (2025)

pathologyoncologyneuro-oncologybrain tumor researchradiation oncologyneuroendocrine disordersjama oncologyendocrine oncology

Framing Theranostic Protocols: Development, Implementation, and Insights From Clinical Practice. Journal of Nuclear Medicine Technology (2025)

theranostic protocolsmedicinetranslational researchinternal medicineclinical implementationintegrative medicineclinical guidanceevidence-based therapiesimplementation researchemergency medicine

Implementation of Dosimetry in Clinical Lu177-Dotatate Therapy. Endocrine Abstracts (2025)

applied pharmacologymedicineclinical lu177-dotatate therapydosimetryoncologyradiation oncologypharmacotherapyclinical researchclinical therapeuticsmedical physics

Navigating Radiation Safety After Radiopharmaceutical Therapies: Proposed Workflow and Essential Guidelines for Nonspecialists. Journal of Nuclear Medicine (2025)

radiation safetynuclear medicinemedicineradiopharmaceutical therapiesoncologyclinical radiation oncologyradiation oncologyradiationradiation therapyradiation biologyradiologyessential guidelinesmedical physics

Phase 1 Study of [177Lu]Lu-Neob in Patients With Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.. Apollo (University of Cambridge) (2025)

gastrointestinal oncologypharmacologypreliminary safetymolecular cancercancer imagingcancer treatmentphase 1cancer researchoncologyradiation oncologypharmacotherapytherapeutic targetsdosimetry results

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: Asco Guideline. JCO Oncology Practice (2025)

Kimberly PerezJaydira Del RiveroErin B. KennedySandip BasuAman ChauhanHeidi M. ConnollyArvind N. DasariAlexandra GangiCallisia N. ClarkeJulie HalletJames R. HoweErin GradyJana IvanidzeErik S. MittraSarah B. WhiteNitya P. RajNamrata VijayvergiaMark A. LewisJennifer A. ChanPamela L. KunzJosh MailmanJunaid ArshadHeloisa P. SoaresSimron SinghChandrika ChandrasekharanMichael C. SoulenEva Tiensuu JansonThorvardur R. HalfdanarsonJonathan R. StrosbergEmily K. Bergsland

treatment optionssurgical oncologyneuroendocrine disordersclinical researchfamily medicineendocrine-related cancerspalliative carecancer researchasco guidelinejama oncologyemergency medicineoncologygastroenterologypalliative medicinecancer caregastrointestinal oncologyurologycarceral settingthoracic oncology

The Current Practice of Theranostics: Results of a National Survey and Lessons Learned. Journal of Nuclear Medicine Technology (2025)

national surveymedicineinternal medicineevidence-based medicinecurrent practiceanesthesiologymedical devicespharmacotherapyclinical researchindividualized medicine

Abstract Ct290: Trial in Progress: Evaluation of the Safety, Tolerability, Whole-Body Distribution, Radiation Dosimetry and Antitumor Activity of 177Lu-Neob in Patients With Advanced Solid Tumors Expressing Gastrin-Releasing Peptide Receptor (Grpr). Cancer Research (2024)

Erik MittraAndrei IagaruAstrid Van der VeldtLuigi AlojJeffrey WongLoic DjailebDhrubajyoti PathakYongmin LiuLilja Solnes

pharmacologyclinical trialsreceptorscancer treatmentcancer biologytumor targetingantitumor activityadvanced solid tumorscancer researchoncologyradiation dosimetryradiation oncologyradiation therapyanti-cancer agentswhole-body distributionclinical researchgastrin-releasing peptide receptor

A Model of Lymphocryptovirus-Associated Post-Transplant Lymphoproliferative Disorder in Immunosuppressed Mauritian Cynomolgus Macaques. PLoS Pathogens (2024)

Helen L. WuWhitney C. WeberCourtney M. WaytashekCarla D. BoyleJason S. ReedKatherine B. BatemanHannah K. FisherYan ChenKimberly ArmantroutTonya SwansonChristine Shriver-MunschMina NorthrupMiranda FischerSreya BiswasJohn TemplonAngela Panoskaltsis-MortariBenjamin J. BurwitzAmanda L. JohnsonLois ColginAnne D. LewisJeremy V. SmedleyMichael K. AxthelmRebecca SkalskyGabrielle MeyersRichard T. MaziarzErik MittraMelissa BergJeffrey J. StantonJonah B. Sacha

pathogensemerging infectious diseasesmicrobiologytransplant infectious diseasesinfectious diseasesvirologypathogenesisimmunosuppressive therapyimmunosuppressionimmunology

1
2
3
4
5
16
10 / page

Erik S. Mittra, M.D., Ph.D.

Professor of Diagnostic Radiology

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Diagnostic Radiology

Division Of Oncological Sciences

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Division Of Molecular Imaging And Therapy

Department Of Diagnostic Radiology

Division Of Nuclear Medicine And Molecular Imaging

Nuclear Medicine and Molecular Imaging

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Erik S. Mittra, M.D., Ph.D.

Oregon Health & Science University

Professor of Diagnostic Radiology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Dosimetry-Guided [ 131 I]Mibg Therapy in a Hemodialysis-Dependent Paraganglioma Patient. Journal of Nuclear Medicine (2025)

mibg therapyurologycancer treatmentdialysis therapyoncologyneuro-oncologybrain tumor researchradiation oncologysurgical oncologypharmacotherapyblood purificationgliomas

Dosimetry of [ 177 Lu]Lu-Dotatate in Patients With Advanced Midgut Neuroendocrine Tumors: Results From a Substudy of the Phase III Netter-1 Trial. Journal of Nuclear Medicine (2025)

pathologyoncologyneuro-oncologybrain tumor researchradiation oncologyneuroendocrine disordersjama oncologyendocrine oncology

Framing Theranostic Protocols: Development, Implementation, and Insights From Clinical Practice. Journal of Nuclear Medicine Technology (2025)

theranostic protocolsmedicinetranslational researchinternal medicineclinical implementationintegrative medicineclinical guidanceevidence-based therapiesimplementation researchemergency medicine

Implementation of Dosimetry in Clinical Lu177-Dotatate Therapy. Endocrine Abstracts (2025)

applied pharmacologymedicineclinical lu177-dotatate therapydosimetryoncologyradiation oncologypharmacotherapyclinical researchclinical therapeuticsmedical physics

Navigating Radiation Safety After Radiopharmaceutical Therapies: Proposed Workflow and Essential Guidelines for Nonspecialists. Journal of Nuclear Medicine (2025)

Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: Asco Guideline. JCO Oncology Practice (2025)

The Current Practice of Theranostics: Results of a National Survey and Lessons Learned. Journal of Nuclear Medicine Technology (2025)

national surveymedicineinternal medicineevidence-based medicinecurrent practiceanesthesiologymedical devicespharmacotherapyclinical researchindividualized medicine

Erik MittraAndrei IagaruAstrid Van der VeldtLuigi AlojJeffrey WongLoic DjailebDhrubajyoti PathakYongmin LiuLilja Solnes

A Model of Lymphocryptovirus-Associated Post-Transplant Lymphoproliferative Disorder in Immunosuppressed Mauritian Cynomolgus Macaques. PLoS Pathogens (2024)

pathogensemerging infectious diseasesmicrobiologytransplant infectious diseasesinfectious diseasesvirologypathogenesisimmunosuppressive therapyimmunosuppressionimmunology

1
2
3
4
5
16
10 / page